GO
Loading...

Corporate Leaders

More

  • Merrill Shares Rise on Hopes for New Leadership Monday, 29 Oct 2007 | 8:17 PM ET
    Merrill Lynch

    Shares of Merrill Lynch rose as investors bet the biggest U.S. brokerage wouldn't keep investors waiting too long before announcing a replacement for Stan O'Neal.

  • Fall of CEO O'Neal Was As Rapid As His Rise Monday, 29 Oct 2007 | 4:28 PM ET
    Stanley O'Neal

    The anticipated departure of Merrill Lynch Chief Executive Stan O'Neal would mark a surprising flameout in a career that had been impressive in its ascent.

  • ASCO: 'Open Door Policy' Levels Playing Field Monday, 29 Oct 2007 | 3:37 PM ET

    TheStreet.com's senior biotech writer Adam Feuerstein broke this story earlier today, but now we've confirmed it independently. The American Society of Clinical Oncology (ASCO) is changing its ways.

  • BlackRock CEO Fink on Short List to Run Merrill Monday, 29 Oct 2007 | 3:08 PM ET
    Larry Fink

    BlackRock Chief Executive Laurence Fink has long been on Wall Street's short lists to run any one of America's top investment houses. Now he may get a chance to prove that he can do the job.

  • Northwest Swings to Profit on Contained Fuel Costs Monday, 29 Oct 2007 | 1:50 PM ET

    Northwest Airlines on Monday said it swung to a profit in the third quarter as it kept fuel and other costs under control and moved on from its bankruptcy restructuring.

  • Chiquita Shares Leap; Firm to Slash Managerial Jobs Monday, 29 Oct 2007 | 12:58 PM ET

    Chiquita Brands International said Monday it will cut 160 management jobs worldwide, close facilities and leave businesses as part of a plan to save $60 million to $80 million a year beginning next year.

  • Stocks Hold, But Merrill Story Stirs Street Monday, 29 Oct 2007 | 8:56 AM ET

    Ahead of the Fed, stocks are holding onto higher ground as oil breaks another record and the dollar flounders. But the high interest story on Wall Street is the behind-the-scenes intrigue at Merrill Lynch as its board struggles to orchestrate the departure and replacement of Merrill Lynch CEO Stan O'Neal.

  • Merrill Considered Naming O'Neal Interim Chairman Sunday, 28 Oct 2007 | 7:17 PM ET
    Stanley O'Neal

    Not long after the Merrill Lynch board of directors agreed to oust Stan O'Neal as the company's chief executive, the same board offered to allow O'Neal to remain in the post on an interim basis, according to a person briefed on the matter.

  • Merrill Lynch Ousts O'Neal; Announcement Is Imminent Sunday, 28 Oct 2007 | 1:39 PM ET
    Stanley O'Neal

    E. Stanley O’Neal has been ousted as chairman and chief executive officer of Merrill Lynch that much is certain as the board of directors of the nation’s largest brokerage firm gets ready to prepare an official announcement.

  • Replacing O'Neal: Who Waits in The Wings? Friday, 26 Oct 2007 | 3:30 PM ET

    If Merrill Lynch Chief Executive Stan O'Neal is forced out, there's little doubt who the firm's army of more than 16,000 brokers would like to see replace him: their own boss.

  • Time Warner Shares Rise on CEO Speculation Friday, 26 Oct 2007 | 2:18 PM ET

    Time Warner  shares rose nearly 4 percent on a report that Chief Executive Richard Parsons plans to announce his exit as early as next week.

  • “Power Lunch” is at the Mall of America outside Minneapolis/St. Paul, to look at alternative energy and consumer activity -- and a surprise definition for "retail stocks." Here's what some of the guests on the program are saying.

  • Merck, Sanofi, Glaxo Get "Shot In The Arm" From U.K. Friday, 26 Oct 2007 | 12:52 PM ET

    British health authorities today announced that starting next fall, all 12- and 13-year-old girls will have to get the controversial shots to prevent the sexually transmitted virus that can lead to cervical cancer. Merck and Sanofi-Aventis are partners on the vaccine Gardasil and the UK-based GlaxoSmithKline makes a similar one Cervarix.

  • Eli Lilly: "Bloom" Is Off The Pipeline Thursday, 25 Oct 2007 | 11:43 AM ET
    Eli Lilly

    If the stock closes down at least 4.46% today (as I write this it is off nearly 7%) Eli Lilly will suffer its worst one-day loss in more than four years, according to our resident statistical expert Robert Hum. If it were to close off more than 7.79%, Hum says it would be the stock's biggest one-day fall since Oct. 23, 2002--almost five years to the day.

  • So Cal Fires Turn Insurance Agents Into "Heroes"  Thursday, 25 Oct 2007 | 9:40 AM ET

    Haven't had much time to blog as I'm out here covering the California wildfires. Wish I could tell you all I've seen but here's at least one slice. For all the problems people sometimes have with their insurance companies, here in Southern California, right now those agents are heroes.

  • CEOs on Parade: Marriott, CME and GlaxoSmithKline Wednesday, 24 Oct 2007 | 3:32 PM ET

    With earnings season underway, CEOs are out talking about their companies. Here's what three of them told CNBC on Wednesday.

  • Merrill CEO: 'Mistakes' Led To Huge Write-Downs Wednesday, 24 Oct 2007 | 1:47 PM ET
    Stanley O'Neal

    Merrill Lynch Chairman and CEO Stan O'Neal told shareholders that  "mistakes" in  subprime lending exposure  led to $7.9 billion in write-downs for the third quarter.

  • Bear Stearns CEO's Health Raises Concerns Wednesday, 24 Oct 2007 | 2:56 AM ET

    Investors are still jittery about the future of Bear Stearns, and they cite several reasons, CNBC has learned.

  • Unibet CEO Petter Nylander is Arrested in Netherlands Tuesday, 23 Oct 2007 | 5:49 AM ET

    The chief executive of online gaming company Unibet Group has been arrested in the Netherlands on a French warrant, the company said Tuesday.

  • Joe Torre And Wal-Mart's Lee Scott: Parallel Lines? Monday, 22 Oct 2007 | 3:56 PM ET

    The world's largest retailer has spawned this blog's biggest response ever! The anti-Wal-Mart emails (some 655, almost all I would say from Wal-Martwatch.com readers) keep pouring into the Retail Detail inbox. We'll continue to post your thoughts and responses so keep them coming. I've yet to hear from any on the pro Wal-Mart side.

Most Popular Video

Wednesday, 23 Apr 2014 | 7:33 AM ET

J. Michael Pearson, Valeant Pharmaceuticals chairman & CEO, explains why he decided to pursue Allergan and shares his R&D business model, with CNBC's Kate Kelly. This year we are launching 19 products in the United States, says Pearson.

Wednesday, 23 Apr 2014 | 6:13 AM ET

Chris Caso, Susquehanna Financial Group analyst, shares his outlook on Apple in the second half. Apple needs to show shareholders the next new thing, says Caso.

Wednesday, 23 Apr 2014 | 4:10 AM ET

Fraser Howie, director at Newedge Singapore, says the PMI data reveals China is "in a bit of a rut" and that the government has a "horrible problem" as it can't bring out too much stimulus.